Skip to content
AwardedSpainGoods€329,387

Adjudicación del Contrato Específico del Medicamento MAVACAMTEN, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari Integral

Published
Published 22 January 2026

Overview

Adjudicación del Contrato Específico del Medicamento MAVACAMTEN, pare el Consorci Sanitari Integral derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, tramitado por el Consorci de Salut i d’Atenció Social de Catalunya

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€329,387
Procedure
Selective
Published
22 January 2026
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€329,387
Award date
19 January 2026
Contract period
19 January 2026 → 14 January 2027
Winner
  • BRISTOL-MYERS SQUIBB SAU

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    22 January 2026

Contracting authority

  • Consorci Sanitari Integral

    Procuring entity

    L’Hospitalet de Llobregat, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Adjudicación del Contrato Específico del Medicamento MAVACAMTEN, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari Integral — won by BRISTOL-MYERS SQUIBB SAU — Skim